BECN1 and melanoma: Further studies showed instead that vemurafenib reduced miR-216b level resulting in upregulation of Beclin-1 (66), has been reported as a mechanism of drug-induced autophagy, allowing vemurafenib-resistant melanoma cells to employ autophagosomes to secret ATP to enhance cell migration and invasion (67).